Oryzon Genomics is committed to the research in neurodegenerative diseases with its drug Vafidemstat (ORY-2001) on World Alzheimer’s Day

The company is running two Phase IIa clinical trials with Vafidemstat in the field of Alzheimer’s Disease

Read More